Zobrazeno 1 - 9
of 9
pro vyhledávání: '"August J. Salvado"'
Autor:
David A, Reardon, Merrill J, Egorin, Jennifer A, Quinn, Jeremy N, Rich, Sridharan, Gururangan, Idharan, Gururangan, James J, Vredenburgh, Annick, Desjardins, Sith, Sathornsumetee, James M, Provenzale, James E, Herndon, Jeannette M, Dowell, Michael A, Badruddoja, Roger E, McLendon, Theodore F, Lagattuta, Kimberly P, Kicielinski, Gregor, Dresemann, John H, Sampson, Allan H, Friedman, August J, Salvado, Henry S, Friedman
Publikováno v:
Journal of Clinical Oncology. 23:9359-9368
Purpose We performed a phase II study to evaluate the combination of imatinib mesylate, an adenosine triphosphate mimetic, tyrosine kinase inhibitor, plus hydroxyurea, a ribonucleotide reductase inhibitor, in patients with recurrent glioblastoma mult
Publikováno v:
Journal of Pediatric Hematology/Oncology. 14:241-247
Thrombocytopenia contributes significantly to morbidity in the sick term or preterm infant. However, few data exist on newborn's megakaryocytes and megakaryocyte progenitor cells (CFU-MK). We therefore studied CFU-MK in term and preterm infant cord b
Autor:
Michael Andreeff, Sherry Pierce, Sima Jeha, Laurie Letvak, Srdan Verstovsek, Miloslav Beran, Guillermo Garcia-Manero, Steven M. Kornblau, Michael J. Keating, Moshe Talpaz, Richard E. Champlin, Susan O'Brien, Stefan Faderl, Hagop M. Kantarjian, Jorge E. Cortes, August J. Salvado, Deborah A. Thomas, Francis J. Giles
Publikováno v:
Blood. 103(12)
Imatinib mesylate, an inhibitor of the Bcr-Abl tyrosine kinase, has modest activity in refractory/relapsed Philadelphia chromosome (Ph)-positive acute lymphocytic leukemia (ALL). Use of concurrent chemotherapy and imatinib mesylate in newly diagnosed
Publikováno v:
Blood. 104:656-656
We previously reported that the erythrocytosis of polycythemia vera was controlled in a small group of patients with imatinib mesylate. This effect may involve inhibition of tyrosine phosphorylation of c-Kit, the stem cell factor receptor essential f
Autor:
Jayashree Krishnan, Svetislava J. Vukelja, Robert D. Knight, August J. Salvado, Christina M. Link
Publikováno v:
American Journal of Hematology. 32:129-133
Pure red cell aplasia (PRCA) rarely occurs in nonthymic lymphoproliferative disorders. This report describes the clinical course and therapy of a patient with a history of Sjogren syndrome who developed well-differentiated lymphocytic lymphoma associ
Publikováno v:
Blood. 59:185-187
Three N-formylated oligopeptides with different known activities as chemotactic factors for leukocytes were studied to determined if these mediators affect the in vitro proliferation of myelomonocytic colony- forming cells (CFU-C) recovered from muri
Publikováno v:
Science (New York, N.Y.). 210(4465)
Clonal lines of Rauscher erythroleukemia cells exhibited selective responses to two inducers of differentiation, erythropoietin and dimethyl sulfoxide. There were substantial quantitiative differences between clones that reponded to both inducers. Se
Granulocyte-macrophage progenitors (CFU-GM) from four patients with childhood onset cyclic neutropenia demonstrated abnormal in vitro proliferative responses to purified, recombinant human granulocyte-macrophage colony-stimulating factor (rhGM-CSF) w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::83107e51356bb9fe0ca91a028685f265
https://europepmc.org/articles/PMC303837/
https://europepmc.org/articles/PMC303837/